# A Two-Part Single and Multiple Ascending Dose Trial of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LBT-3627 in Healthy Participants and in Participants With Parkinson's Disease.

> clinical trial · VERIFIED · 2026-08-21

Status: RECRUITING · Sponsor: Longevity Biotech Australia Pty Ltd (subsidiary) · Condition: Parkinson Disease

- Company: Longevity Biotech Australia Pty Ltd (subsidiary)
- Sector: neurotech
- Primary source: https://clinicaltrials.gov/study/NCT06466525

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.